Marasco WA - Search Results

1

Marasco WA. Marasco WA. Curr Top Microbiol Immunol. 2001;260:247-70. doi: 10.1007/978-3-662-05783-4_13. Curr Top Microbiol Immunol. 2001. PMID: 11443877 Review. No abstract available.

2

Intrabodies: turning the humoral immune system outside in for intracellular immunization.

Marasco WA. Marasco WA. Gene Ther. 1997 Jan;4(1):11-5. doi: 10.1038/sj.gt.3300346. Gene Ther. 1997. PMID: 9068790 Review.

3

Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17.

Levin R, Mhashilkar AM, Dorfman T, Bukovsky A, Zani C, Bagley J, Hinkula J, Niedrig M, Albert J, Wahren B, Göttlinger HG, Marasco WA. Levin R, et al. Among authors: marasco wa. Mol Med. 1997 Feb;3(2):96-110. Mol Med. 1997. PMID: 9085253 Free PMC article.

4

Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.

Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA. Mhashilkar AM, et al. Among authors: marasco wa. J Virol. 1997 Sep;71(9):6486-94. doi: 10.1128/JVI.71.9.6486-6494.1997. J Virol. 1997. PMID: 9261367 Free PMC article.

5

Intracellular antibodies (intrabodies) for gene therapy of infectious diseases.

Rondon IJ, Marasco WA. Rondon IJ, et al. Among authors: marasco wa. Annu Rev Microbiol. 1997;51:257-83. doi: 10.1146/annurev.micro.51.1.257. Annu Rev Microbiol. 1997. PMID: 9343351 Review.

6

Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy.

Marasco WA. Marasco WA. Immunotechnology. 1995 May;1(1):1-19. doi: 10.1016/1380-2933(95)00001-1. Immunotechnology. 1995. PMID: 9373329 Review. No abstract available.

7

Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.

Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA. Mhashilkar AM, et al. Among authors: marasco wa. Hum Gene Ther. 1999 Jun 10;10(9):1453-67. doi: 10.1089/10430349950017798. Hum Gene Ther. 1999. PMID: 10395371

8

Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.

Marasco WA, LaVecchio J, Winkler A. Marasco WA, et al. J Immunol Methods. 1999 Dec 10;231(1-2):223-38. doi: 10.1016/s0022-1759(99)00159-3. J Immunol Methods. 1999. PMID: 10648940 Review.

9

Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.

Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG, Marasco WA. Mhashilkar AM, et al. Among authors: marasco wa. EMBO J. 1995 Apr 3;14(7):1542-51. doi: 10.1002/j.1460-2075.1995.tb07140.x. EMBO J. 1995. PMID: 7537216 Free PMC article.

10

Intracellular antibodies as a new class of therapeutic molecules for gene therapy.

Chen SY, Bagley J, Marasco WA. Chen SY, et al. Among authors: marasco wa. Hum Gene Ther. 1994 May;5(5):595-601. doi: 10.1089/hum.1994.5.5-595. Hum Gene Ther. 1994. PMID: 7914435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters